Management of dyslipidemia in children

Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as dyslipidemia is an important risk factor for CVD, screening and treatment of dyslipidemia in adolescents and children becom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Gandhi, Arun, Kalra, Bharti, Agrawal, Navneet
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794840/
https://www.ncbi.nlm.nih.gov/pubmed/19995441
http://dx.doi.org/10.1186/1758-5996-1-26
_version_ 1782175399992623104
author Kalra, Sanjay
Gandhi, Arun
Kalra, Bharti
Agrawal, Navneet
author_facet Kalra, Sanjay
Gandhi, Arun
Kalra, Bharti
Agrawal, Navneet
author_sort Kalra, Sanjay
collection PubMed
description Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as dyslipidemia is an important risk factor for CVD, screening and treatment of dyslipidemia in adolescents and children becomes an important health matter. This review deals with issues related to screening, diagnosis and treatment of dyslipidemia in children and adolescents.
format Text
id pubmed-2794840
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27948402009-12-17 Management of dyslipidemia in children Kalra, Sanjay Gandhi, Arun Kalra, Bharti Agrawal, Navneet Diabetol Metab Syndr Review Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as dyslipidemia is an important risk factor for CVD, screening and treatment of dyslipidemia in adolescents and children becomes an important health matter. This review deals with issues related to screening, diagnosis and treatment of dyslipidemia in children and adolescents. BioMed Central 2009-12-08 /pmc/articles/PMC2794840/ /pubmed/19995441 http://dx.doi.org/10.1186/1758-5996-1-26 Text en Copyright ©2009 Kalra et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kalra, Sanjay
Gandhi, Arun
Kalra, Bharti
Agrawal, Navneet
Management of dyslipidemia in children
title Management of dyslipidemia in children
title_full Management of dyslipidemia in children
title_fullStr Management of dyslipidemia in children
title_full_unstemmed Management of dyslipidemia in children
title_short Management of dyslipidemia in children
title_sort management of dyslipidemia in children
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794840/
https://www.ncbi.nlm.nih.gov/pubmed/19995441
http://dx.doi.org/10.1186/1758-5996-1-26
work_keys_str_mv AT kalrasanjay managementofdyslipidemiainchildren
AT gandhiarun managementofdyslipidemiainchildren
AT kalrabharti managementofdyslipidemiainchildren
AT agrawalnavneet managementofdyslipidemiainchildren

Ejemplares similares